Matthew Snape, associate professor of pediatrics and vaccines at the University, said OxfordAnd the chief researcher of the experiment: “If we show that these vaccines can be used interchangeably in the same schedule, this will greatly increase the flexibility of vaccine delivery, and it could provide new information on how to increase protection against new virus strains.”
The new experiment will recruit more than 800 volunteers aged 50 and over from 8 sites supported by the National Institute for Health Research in Britain You will evaluate the experiment.
According to the steps of the experiment, the volunteer will be vaccinated with a first dose of the “Oxford – AstraZeneca” vaccine, followed by a second dose of the Pfizer vaccine, or vice versa.
Using blood samples collected from volunteers in the experiment, the study will monitor the effect of different dose regimens on the participants’ immune responses, and for any additional negative reactions to the new formulations of vaccines, and the study will continue for 13 months.
Professor Snape added: “This is a very exciting study that will provide vital information that will aid in the vaccination plan in India Britain “.
“We invite those 50 years of age or older who have not received a vaccine,” he added.Covid-19After, to visit the website to find out more about the study, and to find out if there is a study registration center near them.